Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Cyclin D1 (CCND1) (Middle Region) Peptid

CCND1 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN974599

Kurzübersicht für Cyclin D1 (CCND1) (Middle Region) Peptid (ABIN974599)

Target

Cyclin D1 (CCND1)

Spezies

Human

Quelle

  • 14
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-CCND1 antibody (Catalog #: AVARP03037_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    Cyclin D1 (CCND1)

    Hintergrund

    CCND1 belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis.The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

    Alias Symbols: BCL1, D11S287E, PRAD1, U21B31

    Protein Interaction Partner: CHUK,CREBBP,CTNNB1,ERCC3,ESR1,NCOA3,POLR2A,RELA,BRCA1,CDK4,CDK4,CDK6,CDKN1A,CDKN1A,CDKN1A,CDKN1B,KLF6,PIN1,RB1,TAF1,FOXO4,AKAP8,AR,BRCA1,CALM1,CCNDBP1,CDK4,CDK6,CDKN1A,CDKN1B,CTNNB1,CUL3,DMTF1,EP300,ESR1,GSK3B,HDAC3,HERC5,IFI27,INSM1,KAT2B,MCM10,MYBL2,NCOA1,NCOA3,NPDC1,ORC4L,PCNA,PRKACA,RB1,RBL1,RBL2,RBX1,RFC1,RUNX1,SP1,STAT3,TAF1,THRA,THRB,TSC2,CREB1,EGFR,STAT3,AKAP8,AR,BRCA1,CCNDBP1,CDK4,CDK6,CDKN1A,CDKN1B,CDKN1C,CDKN2A,EP300,ESR1,HDAC3,HERC5,KAT2B,Mybl2,NCOA1,NCOA3,NEUROD1,NPDC1,PCNA,RB1,RBX1,RFC1,STAT3,TAF1,THRA,THRB,TSC2,XPO1

    Protein Size: 295

    Molekulargewicht

    34 kDa

    Gen-ID

    595

    NCBI Accession

    NM_053056, NP_444284

    UniProt

    P24385
Sie sind hier:
Chat with us!